Sandoz To Pay $195M Penalty For 4 Antitrust Violations In Generic Drug Trade
PHILADELPHIA — Generic drug manufacturer Sandoz Inc. on March 2 agreed to a three-year deferred prosecution agreement for four antitrust violations in a Pennsylvania federal court and agreed to pay a...To view the full article, register now.
Already a subscriber? Click here to view full article